IPS-3 Validation in 1012 cases with classical hodgkin lymphoma
Paydas, Semra, Laçin, Sahin, Doğan, Mutlu, Barista, Ibrahim, Yildiz, Birol, Seydaoglu, Gulsah, Karadurmus, Nuri, Civriz, Sinem, Kaplan, Muhammed Ali, Yagci, Munci, Gurkan, Emel, Ercolak, Vehbi
Published in Leukemia research (01.03.2021)
Published in Leukemia research (01.03.2021)
Get full text
Journal Article
ARA-C associated pulmonary toxicity / ARA-C iliskili akciger toksisitesi
Yegin, Zeynep Arzu, Sucak, Gulsan Turkoz, Erbas, Gonca, Yagci, Munci
Published in Turkish journal of haematology (01.03.2011)
Published in Turkish journal of haematology (01.03.2011)
Get full text
Journal Article
Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: Risk factors and impact on mortality
Turkoglu, Melda, MD, Mirza, Emel, MD, Tunçcan, Özlem Güzel, MD, Erdem, Gökmen Umut, MD, Dizbay, Murat, MD, Yağcı, Münci, MD, Aygencel, Gülbin, MD, Türköz Sucak, Gülsan, MD
Published in Journal of critical care (01.10.2011)
Published in Journal of critical care (01.10.2011)
Get full text
Journal Article
Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience
Özbalak, Murat, Salihoğlu, Ayşe, Soysal, Teoman, Karadoğan, İhsan, Paydaş, Semra, Özdemir, Evren, Yıldız, Birol, Karadurmuş, Nuri, Kaynar, Leylagül, Yagci, Münci, Özkocaman, Vildan, Topçuoğlu, Pervin, Özcan, Muhit, Birtaş, Elif, Göker, Hakan, Ferhanoglu, Burhan
Published in Annals of hematology (01.02.2020)
Published in Annals of hematology (01.02.2020)
Get full text
Journal Article
Autonomic nervous system dysfunction and serum levels of neurotoxic and neurotrophic cytokines in patients with cobalamin deficiency / Kobalamin eksikligi olan hastalarda otonom sinir sistemi bozuklugu ve norotoksik, norotropik sitokinlerin serum duzeyleri
Ceneli, Ozcan, Aki, Sahika Zeynep, Kucuk, Betul Cevik, Tokcaer, Ayse Bora, Kuruoglu, Reha, Yagci, Munci
Published in Turkish journal of haematology (01.12.2010)
Published in Turkish journal of haematology (01.12.2010)
Get full text
Journal Article
Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
Niemann, Carsten U, Munir, Talha, Moreno, Carol, Owen, Carolyn, Follows, George A, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Robak, Tadeusz, Simkovic, Martin, Voloshin, Sergey, Vorobyev, Vladimir, Yagci, Munci, Ysebaert, Loic, Qi, Keqin, Qi, Qianya, Sinet, Pierre, Parisi, Lori, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Howes, Angela, Caces, Donne Bennett, Kater, Arnon P
Published in The lancet oncology (01.12.2023)
Published in The lancet oncology (01.12.2023)
Get full text
Journal Article
Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma
Paydas, Semra, Lacin, Sahin, Dogan, Mutlu, Barista, Ibrahim, Yildiz, Birol, Seydaoglu, Gulsah, Karadurmus, Nuri, Civriz, Sinem, Kaplan, Muhammed Ali, Yagci, Munci, Dincyurek, Huseyin Derya, Ercolak, Vehbi
Published in Leukemia research (01.08.2021)
Published in Leukemia research (01.08.2021)
Get full text
Journal Article
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study
Munir, Talha, Moreno, Carol, Owen, Carolyn, Follows, George, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Osterborg, Anders, Robak, Tadeusz, Simkovic, Martin, Stevens, Don, Voloshin, Sergey, Vorobyev, Vladimir, Yagci, Munci, Ysebaert, Loic, Qi, Keqin, Qi, Qianya, Parisi, Lori, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Howes, Angela, Caces, Donne Bennett, Niemann, Carsten U, Kater, Arnon P
Published in Journal of clinical oncology (20.07.2023)
Published in Journal of clinical oncology (20.07.2023)
Get full text
Journal Article
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
Broome, Catherine M, McDonald, Vickie, Miyakawa, Yoshitaka, Carpenedo, Monica, Kuter, David J, Al-Samkari, Hanny, Bussel, James B, Godar, Marie, Ayguasanosa, Jaume, De Beuf, Kristof, Rodeghiero, Francesco, Michel, Marc, Newland, Adrian, Fillitz, Michael, Knoebl, Paul, Meers, Stef, Amine, Ismail Mohamad, Gumulec, Jaromir, Hlusi, Antonin, Mayer, Jiri, Quittet, Philippe, Viallard, Jean-Francois, Betaneli, Magdana, Datikashvili-David, Irine, Iosava, Genadi, Makhaldiani, Levan, Rejto, Laszlo, Sharashenidze, Nino, Groepper, Stefanie, Röth, Alexander, Hamed, Aryan, Illes, Arpad, Artoni, Andrea, Bocchia, Monica, Gamberi, Barbara, Borchiellini, Alessandra, Oliva, Esther Natalie, Patriarca, Andrea, Tomassetti, Simona, Ando, Kiyoshi, Handa, Hiroshi, Katsutani, Shinya, Nishiwaki, Kaichi, Ito, Shoko, Ito, Tomoki, de Boer, Fransien, Jansen, A.J. Gerard, Ciepluch, Hanna, Fornagiel, Szymon, Grosicki, Sebastian, Soroka-Wojtaszko, Maria, Trelinski, Jacek, Bakirov, Bulat, Borisenkova, Elena, Volodicheva, Elena, Shatokhin, Yuri, Proydakov, Andrey, Alonso, Maria Aranzazu, Mingot-Castellano, María Eva, Sanchez-Gonzalez, Blanca, Valcarcel Ferreiras, David, Ayli, Meltem, Hacibekiroglu, Tuba, Demir, Ahmet Muzaffer, Nalçaci, Meliha, Sonmez, Mehmet, Tombak, Anil, Toprak, Selami Kocak, Turgut, Burhan, Vural, Filiz, Yagci, Munci, Altuntas, Fevzi, Turgut, Mehmet, Kaya, Emin, Romanyuk, Nataliya, Kazmi, Syed Rashid Saeed, Broome, Catherine, Cataland, Spero, Doshi, Ketan, Lentz, Steven R., Boxer, Michael, Rosenberg, Richard
Published in The Lancet (British edition) (04.11.2023)
Published in The Lancet (British edition) (04.11.2023)
Get full text
Journal Article
Residual Disease Kinetics Among Patients with High-Risk Factors Treated with First-Line Fixed-Duration Ibrutinib Plus Venetoclax (Ibr+Ven) Versus Chlorambucil Plus Obinutuzumab (Clb+O): The Glow Study
Niemann, Carsten U, Munir, Talha, Moreno, Carol, Owen, Carolyn, Follows, George A, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Österborg, Anders, Robak, Tadeusz, Šimkovič, Martin, Voloshin, Sergey, Vorobyev, Vladimir I., Yagci, Munci, Ysebaert, Loic, Qi, Keqin, Qi, Qianaya, Parisi, Lori, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Howes, Angela, Bennett Caces, Donne, Kater, Arnon P.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment
Oriol, Albert, Dimopoulos, Meletios, Schjesvold, Fredrik, Beksac, Meral, Facon, Thierry, Dhanasiri, Sujith, Guo, Shien, Mu, Yutian, Hong, Kevin, Gentili, Christian, Galli, Monica, Yagci, Munci, Larocca, Alessandra, Richardson, Paul, Weisel, Katja
Published in Clinical lymphoma, myeloma and leukemia (01.03.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.03.2024)
Get full text
Journal Article
Multicenter Early Access Program Results from Turkey: Efficacy and Safety of Daratumumab Among Heavily Pretreated Relapse/Refractory Multiple Myeloma Patients
Beksac, Meral, Aydin, Yildiz, Goker, Hakan, Turgut, Mehmet, Besisik, Sevgi Kalayoglu, Cagirgan, Seckin, Tuglular, Tulin F, Vural, Filiz, Yagci, Munci
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
First-Line Fixed-Duration Ibrutinib Plus Venetoclax (Ibr+Ven) vs Chlorambucil Plus Obinutuzumab (Clb+O): 55-Month Follow-Up From the GLOW Study
Moreno, Carol, Munir, Talha, Owen, Carolyn, Follows, George, Hernández-Rivas, José-Ángel, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Robak, Tadeusz, Simkovic, Martin, Voloshin, Sergey, Vorobyev, Vladimir, Yagci, Munci, Ysebaert, Loic, Qi, Qianya, Smith, Emma, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Bennett Caces, Donne, Niemann, Carsten, Kater, Arnon
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
CLL-487 First-Line Fixed-Duration Ibrutinib Plus Venetoclax (Ibr+Ven) vs Chlorambucil Plus Obinutuzumab (Clb+O): 55-Month Follow-Up From the GLOW Study
Moreno, Carol, Munir, Talha, Owen, Carolyn, Follows, George, Hernández-Rivas, José-Ángel, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Robak, Tadeusz, Simkovic, Martin, Voloshin, Sergey, Vorobyev, Vladimir, Yagci, Munci, Ysebaert, Loic, Qi, Qianya, Smith, Emma, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Bennett Caces, Donne, Niemann, Carsten, Kater, Arnon
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment
Oriol, Albert, Dimopoulos, Meletios, Schjesvold, Fredrik Hellem, Beksac, Meral, Facon, Thierry, Dhanasiri, Sujith, Guo, Shien, Mu, Yutian, Hong, Kevin, Gentili, Christian, Galli, Monica, Yagci, Munci, Larocca, Alessandra, Richardson, Paul, Weisel, Katja
Published in Clinical lymphoma, myeloma and leukemia (2023)
Get full text
Published in Clinical lymphoma, myeloma and leukemia (2023)
Journal Article
Extranodal multifocal Rosai–Dorfman disease: response to 2-chlorodeoxyadenosine treatment
Konca, Ceyla, Özkurt, Zübeyde N., Deger, Müge, Akı, Zeynep, Yağcı, Münci
Published in International journal of hematology (01.01.2009)
Published in International journal of hematology (01.01.2009)
Get full text
Journal Article
Effect of Different Treatment Patterns to Cost Effectiveness in Chronic Lymphocytic Leukemia Patients, Turkish CLL Study Group
Demirkan, Fatih, Vural, Filiz, Tekinalp, Atakan, Sevindik, Omur Gokmen, Sayinalp, Nilgun, Kaynar, Leylagul, Erkurt, Mehmet Ali, Kabukcu Hacioglu, Sibel, Yagci, Munci, Turgut, Burhan
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article